ConductScience.org, home

Paper36768328

Targeting Agents in Biomaterial-Mediated Bone Regeneration.

Gisbert-Garzarán M and 2 others. Int J Mol Sci, 2023. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Targeting Agents in Biomaterial-Mediated Bone Regeneration. Papers, record 36768328. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36768328

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeting Agents in Biomaterial-Mediated Bone Regeneration.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.79
iCite
Revised in PubMed
2023-02-14
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gisbert-Garzarán MMiguelhttps://orcid.org/0000-0001-9815-0354
2Gómez-Cerezo MNMaría Natividad
3Vallet-Regí MMaríahttps://orcid.org/0000-0002-6104-4889

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biocompatible MaterialsMajor topic
Bone DiseasesMajor topic
Humans
Tissue Scaffolds
Tissue Engineering
Bone Regeneration

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
694160European Research CouncilInternationalPubMed

Source PubMed

Download CSV of grants

References136

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130429885Increased recruitment of endogenous stem cells and chondrogenic differentiation by a composite scaffold containing bone marrow homing peptide for cartilage regeneration.Theranostics2018https://conductscience.org/library/papers/30429885PubMed
226871889Ectopic bone formation in rapidly fabricated acellular injectable dense collagen-Bioglass hybrid scaffolds via gel aspiration-ejection.Biomaterials2016https://conductscience.org/library/papers/26871889PubMed
316341622The role of collagen in bone strength.Osteoporos Int2006https://conductscience.org/library/papers/16341622PubMed
429415986Osteoblast-targeted delivery of miR-33-5p attenuates osteopenia development induced by mechanical unloading in mice.Cell Death Dis2018https://conductscience.org/library/papers/29415986PubMed
531806966Novel Aptamer-Functionalized Nanoparticles Enhances Bone Defect Repair By Improving Stem Cell Recruitment.Int J Nanomedicine2019https://conductscience.org/library/papers/31806966PubMed
630431109Enhanced adhesion and proliferation of bone marrow mesenchymal stem cells on β‑tricalcium phosphate modified by an affinity peptide.Mol Med Rep2019https://conductscience.org/library/papers/30431109PubMed
729761314PCL-Based Composite Scaffold Matrices for Tissue Engineering Applications.Mol Biotechnol2018https://conductscience.org/library/papers/29761314PubMed
836176622Integrated bioactive scaffold with aptamer-targeted stem cell recruitment and growth factor-induced pro-differentiation effects for anisotropic meniscal regeneration.Bioeng Transl Med2022https://conductscience.org/library/papers/36176622PubMed
926230358Differential Expression of Adhesion-Related Proteins and MAPK Pathways Lead to Suitable Osteoblast Differentiation of Human Mesenchymal Stem Cells Subpopulations.Stem Cells Dev2015https://conductscience.org/library/papers/26230358PubMed
1020204595Osteocyte: the unrecognized side of bone tissue.Osteoporos Int2010https://conductscience.org/library/papers/20204595PubMed
1128453953Dual-functioning peptides discovered by phage display increase the magnitude and specificity of BMSC attachment to mineralized biomaterials.Biomaterials2017https://conductscience.org/library/papers/28453953PubMed
1211697106Novel drug delivery system to bone using acidic oligopeptide: pharmacokinetic characteristics and pharmacological potential.J Drug Target2001https://conductscience.org/library/papers/11697106PubMed
1317141175Effect of therapeutic levels of doxycycline and minocycline in the proliferation and differentiation of human bone marrow osteoblastic cells.Arch Oral Biol2007https://conductscience.org/library/papers/17141175PubMed
1429386866Osteoporosis: A Review of Treatment Options.P T2018https://conductscience.org/library/papers/29386866PubMed
1520161446Chemical and Biochemical Basis of Cell-Bone Matrix Interaction in Health and Disease.Curr Chem Biol2009https://conductscience.org/library/papers/20161446PubMed
1631678741Silicon substituted hydroxyapatite/VEGF scaffolds stimulate bone regeneration in osteoporotic sheep.Acta Biomater2020https://conductscience.org/library/papers/31678741PubMed
1711000347Bioglass 45S5 stimulates osteoblast turnover and enhances bone formation In vitro: implications and applications for bone tissue engineering.Calcif Tissue Int2000https://conductscience.org/library/papers/11000347PubMed
1831968690Mesoporous Silica Nanoparticles for the Treatment of Complex Bone Diseases: Bone Cancer, Bone Infection and Osteoporosis.Pharmaceutics2020https://conductscience.org/library/papers/31968690PubMed
1918775204Bisphosphonates: mechanism of action and role in clinical practice.Mayo Clin Proc2008https://conductscience.org/library/papers/18775204PubMed
2031820299Biphasic composite of calcium phosphate-based mesoporous silica as a novel bone drug delivery system.Drug Deliv Transl Res2020https://conductscience.org/library/papers/31820299PubMed

See all 136 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42927301Engineering exosomes-mediated RNA delivery regulates bone homeostasis and alleviates osteoporosis.Mater Today Bio2026https://conductscience.org/library/papers/42927301PubMed
42591521Recent advances in multimodal foundation model-enabled peptide screening and optimization for smart biomaterials and functional tissue engineering.Front Bioeng Biotechnol2026https://conductscience.org/library/papers/42591521PubMed
41560823Functional nucleic acid Hydrogels: Paving the way for Next-generation bone and cartilage regeneration.Mater Today Bio2026https://conductscience.org/library/papers/41560823PubMed
40529298Advantages, applications, and future directions of in vivo aptamer SELEX: A review.Mol Ther Nucleic Acids2025https://conductscience.org/library/papers/40529298PubMed
398664993D scaffold of hydroxyapatite/β tricalcium phosphate from mussel shells: Synthesis, characterization and cytotoxicity.Heliyon2025https://conductscience.org/library/papers/39866499PubMed
39846662Relationship of Chronic Stress and Hypertension with Bone Resorption.J Funct Morphol Kinesiol2025https://conductscience.org/library/papers/39846662PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36768328

GET https://conductscience.org/api/papers/v1/36768328/references?page=2